Visit COVID-19 resources

[Skip to Content]

Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study) – (Eye 31, 1253 (September 2017))

Sep 14
2017

Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study) Eye 31, 1253 (September 2017). doi:10.1038/eye.2017.75 Authors: O Comyn, L Wickham, D G Charteris, P M Sullivan, E Ezra, Z Gregor, G W Aylward, L da Cruz, D Fabinyi, T Peto, M Restori, W Xing, C Bunce, P G Hykin & J

  • 14 September 2017

European Leadership Development Programme (EuLDP) Class of 2017 -2019

Sep 07
2017

The European Society of Ophthalmology, (SOE) invites UK Ophthalmologists and Residents to submit their interest to join the EuLDP Class of 2017 – 2019. The programme aims to Identify future leaders in European ophthalmology and provide them with an informal network of peers Provide a basic leadership training programme adapted for ophthalmology Enhance advocacy issues

  • 7 September 2017

New help for ‘acid attack’ victims following recent rise in demand for NHS help

Sep 06
2017

The NHS and leading burns surgeons have issued new first aid guidance to help ensure victims of acid attacks get the right help fast. The assistance for victims comes as new data from NHS England show the number of people requiring specialist medical help for this type of assault is on the rise. In 2014,

  • 6 September 2017

Posts available on the Education and Training Committees

Sep 06
2017

Several new and current posts on both the Education and Training Committees are now available for application via the RCOphth website. The work of these committees ensure that patients are treated by safe and competent doctors by facilitating the acquisition of appropriate knowledge, understanding, skills, values and attitudes. On the Education Committee these roles include an

  • 6 September 2017

British Council for Prevention of Blindness (BCPB) Grants available

Sep 06
2017

BCPB aims to target the most resource deprived populations for benefit through the funding of research into blindness prevention. Low and lower middle income World Bank categories are regarded by BCPB as the areas in greatest need. Applications for work in upper middle income countries may exceptionally be supported, provided the major impact of the research is

  • 6 September 2017